药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Penfluridol
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Penfluridol.
Metacycline
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Dexchlorpheniramine.
Metacycline
Lorcainide
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Lorcainide.
Metacycline
Bunaftine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Bunaftine.
Metacycline
Nizofenone
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Nizofenone.
Metacycline
Otilonium
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Otilonium.
Metacycline
Sultopride
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Sultopride.
Metacycline
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Sitafloxacin.
Metacycline
Oxatomide
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Oxatomide.
Metacycline
Abexinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Abexinostat.
Metacycline
Mizolastine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Mizolastine.
Metacycline
Ricolinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Ricolinostat.
Metacycline
Simendan
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Simendan.
Metacycline
CUDC-101
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with CUDC-101.
Metacycline
Entinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Entinostat.
Metacycline
Mocetinostat
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Mocetinostat.
Metacycline
Amifampridine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Amifampridine.
Metacycline
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Dexchlorpheniramine maleate.
Metacycline
Benidipine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Benidipine.
Metacycline
Butriptyline
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Butriptyline.